GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (BOM:524412) » Definitions » Degree of Financial Leverage

Aarey Drugs & Pharmaceuticals (BOM:524412) Degree of Financial Leverage : 8.86 (As of Dec. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals Degree of Financial Leverage?

Degree of Financial Leverage (DFL) measures the percentage change in EPS for a unit change in Earnings Before Interest and Taxes (EBIT). Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage for the quarter that ended in Dec. 2024 was 8.86. The higher Degree of Financial Leverage, the more volatile earnings will be.

The industry rank for Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage or its related term are showing as below:

BOM:524412's Degree of Financial Leverage is ranked worse than
97.35% of 981 companies
in the Drug Manufacturers industry
Industry Median: 0.99 vs BOM:524412: 8.86

Aarey Drugs & Pharmaceuticals Degree of Financial Leverage Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarey Drugs & Pharmaceuticals Degree of Financial Leverage Chart

Aarey Drugs & Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Degree of Financial Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.49 0.56 1.94 3.20

Aarey Drugs & Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Degree of Financial Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.71 3.20 3.30 5.10 8.86

Competitive Comparison of Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage

For the Drug Manufacturers - Specialty & Generic subindustry, Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage, along with its competitors' market caps and Degree of Financial Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage distribution charts can be found below:

* The bar in red indicates where Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage falls into.


;
;

Aarey Drugs & Pharmaceuticals Degree of Financial Leverage Calculation

Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage for the quarter that ended in Dec. 2024 is calculated as:

Degree of Financial Leverage=% Change in Earnings per Share (Diluted)**/% Change in EBIT
=( 2.11 (Dec. 2024) / 0.79 (Dec. 2023) - 1 )/( 110.764 (Dec. 2024) / 93.188 (Dec. 2023) - 1 )
=1.6709/0.1886
=8.86***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EPS and EBIT was used to calculate Degree of Financial Leverage.
*** Please be aware that the Degree of Financial Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Aarey Drugs & Pharmaceuticals  (BOM:524412) Degree of Financial Leverage Explanation

Degree of Financial Leverage (DFL) is a leverage ratio that measures the sensitivity of a company’s Earnings per Share (EPS) to fluctuations in its operating income, also referred to as Earnings Before Interest and Taxes (EBIT), resulting from adjustments in its capital structure. DFL is an essential tool for companies to assess the appropriate level of debt or financial leverage in their capital structure. When EBIT remains relatively stable, it results in stable earnings and earnings per share. In such cases, the company may consider taking on substantial debt. However, for companies operating in industries with significant fluctuations in EBIT, it is advisable to keep debt at a manageable level.

The higher Degree of Financial Leverage, the more volatile earnings will be. Because interest is a fixed expense, leverage can amplify earnings and EPS. This is beneficial when EBIT is growing, but it can become problematic in tough economic conditions when EBIT is under pressure.

Be Aware

The use of financial leverage varies across different industries and business sectors, and the application of Degree of Financial Leverage (DFL) should be adjusted accordingly.


Aarey Drugs & Pharmaceuticals Degree of Financial Leverage Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's Degree of Financial Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarey Drugs & Pharmaceuticals Business Description

Traded in Other Exchanges
Address
340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid Bunder, Mumbai, MH, IND, 400 009
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, and BMD among others. The company principally carries out its business operations in India.

Aarey Drugs & Pharmaceuticals Headlines

No Headlines